Federal Register / Vol. 89, No. 235 / Friday, December 6, 2024 / Notices 97071 

Carolina 29418–8305, applied to be 

registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Marihuana Extract ........... 7350 I 

Marihuana ........................ 7360 I 

Tetrahydrocannabinols .... 7370 I 

Psilocybin ........................ 7437 I 

Psilocyn ........................... 7438 I 

The company plans to import the 

listed controlled substances to produce 

analytical reference standards for sale 

and distribution to its customers. Drug 

codes 7350 (Marihuana Extract) and 

7360 (Marihuana) will be used for the 

manufacture of cannabidiol only. In 

reference to drug code 7370 

(Tetrahydrocannabinols) the company 

plans to import a synthetic version of 

this controlled substance. No other 

activities for these drug codes are 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2024–28717 Filed 12–5–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1462] 

Importer of Controlled Substances 

Application: Noramco 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Noramco has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTARY INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before January 6, 2025. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 6, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on October 9, 2024, 

Noramco, 500 Swedes Landing Road, 

Wilmington, Delaware 19801–4417, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric 

Acid.

2010 I 

Marihuana ........................ 7360 I 

Tetrahydrocannabinols .... 7370 I 

Methadone-Intermediate 9254 II 

Opium, Raw ..................... 9600 II 

Opium Extracts ................ 9610 II 

Opium Fluid Extract ......... 9620 II 

Opium Tincture ................ 9630 II 

Opium, Powdered ............ 9639 II 

Opium, Granulated .......... 9640 II 

Opium Poppy/Poppy 

Straw.

9650 II 

Noroxymorphone ............. 9668 II 

Poppy Straw Concentrate 9670 II 

Tapentadol ...................... 9780 II 

The company plans to import Poppy 

Straw Concentrate (9670) to bulk 

manufacture other controlled substances 

for distribution to its customers. The 

company plans to import an 

intermediate form of Tapentadol (9780) 

to bulk manufacture Tapentadol for 

distribution to its customers. In 

reference to drug codes 7360 

(Marihuana) and 7370 

(Tetrahydrocannabinols), the company 

plans to import a synthetic cannabidiol 

and a synthetic Tetrahydrocannabinol. 

No other activities for these drug codes 

are authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2024–28728 Filed 12–5–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the Clean Air 

Act 

On December 2, 2024, the Department 

of Justice lodged a proposed Consent 

Decree with the United States District 

Court for the Western District of 

Missouri in the lawsuit entitled United 

States of America v. BCP Ingredients, 

Inc. Civ. No. 3:24–cv–5094 (W.D. Mo.). 

The Complaint seeks injunctive relief 

and civil penalties for alleged violations 

of section 112(r) of the Federal Clean 

Air Act (‘‘CAA’’), 42 U.S.C. 7412(r)(7), 

and its implementing regulations set 

forth at 40 CFR part 68, resulting from 

a release of ethylene oxide (‘‘EtO’’) at a 

chemical manufacturing and repackaging facility owned and operated 

by BCP Ingredients, Inc. (‘‘BCP’’) in 

Verona, Missouri. Under the proposed 

Consent Decree resolving these alleged 

violations, BCP will pay a civil penalty 

of $300,000 to the United States, install 

an additional state-of-the-art EtO 

scrubber to reduce EtO emissions at its 

facility, and share a copy of its final 

audit completion report from a 2022 

third party audit. BCP also will be 

required to perform three Supplemental 

Environmental Projects totaling 

$350,000: (1) donation of two vehicles 

to a local healthcare provider to provide 

mobile health services to communities 

near BCP’s facility; (2) provision of at 

least 1,000 medical visits to be 

administered by the same local 

healthcare provider using the vehicles 

BCP will donate for the first SEP; and 

(3) donation of emergency response 

equipment to a fire department near 

BCP’s facility. 

The publication of this notice opens 

a period for public comment on the 

proposed Consent Decree. Comments 


lotter on DSK11XQN23PROD with NOTICES1
97072 Federal Register / Vol. 89, No. 235 / Friday, December 6, 2024 / Notices 

should be addressed to the Assistant 

Attorney General, Environment and 

Natural Resources Division, and should 

refer to United States of America v. BCP 

Ingredients, Inc. Civ. No. 3:24–cv–5094 

(W.D. Mo.), D.J. Ref. No. 90–5–2–1– 

12805. All comments must be submitted 

no later than thirty (30) days after the 

publication date of this notice. 

Comments may be submitted either by 

email or by mail: 

To submit 

comments: Send them to: 

By email ....... pubcomment-ees.enrd@

usdoj.gov. 

By mail ......... Assistant Attorney General, 

U.S. DOJ—ENRD, P.O. 

Box 7611, Washington, DC 

20044–7611. 

During the public comment period, 

the consent decree may be examined 

and downloaded at this Justice 

Department website: https://

www.justice.gov/enrd/consent-decrees. 

If you require assistance accessing the 

consent decree, you may request 

assistance by email or mail to the 

addresses provided above for submitting 

comments. 

Kathryn C. Macdonald, 

Assistant Section Chief, Environmental 

Enforcement Section, Environment and 

Natural Resources Division. 

[FR Doc. 2024–28710 Filed 12–5–24; 8:45 am] 

BILLING CODE 4410–15–P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act and Formerly Utilized Sites 

Remedial Action Program 

On December 2, 2024, the Department 

of Justice lodged a proposed Consent 

Decree with the United States District 

Court for the Eastern District of Missouri 

in the lawsuit entitled United States v. 

Cotter Corporation (N.S.L.) and Norfolk 

Southern Railway Company, Civil 

Action No. 24–cv–1593. 

The United States filed this lawsuit 

under the Comprehensive 

Environmental Response, 

Compensation, and Liability Act 

(CERCLA) and the Formerly Utilized 

Sites Remedial Action Program 

(FUSRAP) for response costs incurred, 

and to be incurred, by the United States 

Army Corps of Engineers (the Corps) 

and Department of Defense for their 

removing contamination from uranium 

ore or residue processing materials at 

certain portions of the North St. Louis 

County Superfund Site in Missouri. 

Under the proposed Consent Decree, 

Cotter Corporation, Norfolk Southern 

Railway Company, and the United 

States will pay a combined total of 

nearly $164,000,000 in past and future 

response costs for costs associated with 

the above activities. In return, the 

proposed Consent Decree provides 

Cotter, Norfolk Southern, and the 

United States with a covenant not to sue 

or take administrative action under 

section 107(a) of CERCLA for any costs 

associated with the above activities at 

the North St. Louis County Site, as well 

as contribution protection under section 

113(f)(2) of CERCLA. 

The publication of this notice opens 

a period for public comment on the 

proposed Consent Decree. Comments 

should be addressed to the Assistant 

Attorney General, Environment and 

Natural Resources Division, and should 

refer to United States v. Cotter 

Corporation (N.S.L.) and Norfolk 

Southern Railway Company, D.J. Ref. 

No. 90–11–2–08259/3. All comments 

must be submitted no later than thirty 

(30) days after the publication date of 

this notice. Comments may be 

submitted either by email or by mail: 

To submit 

comments: Send them to: 

By e-mail ...... pubcomment-ees.enrd@

usdoj.gov. 

By mail ......... Assistant Attorney General, 

U.S. DOJ—ENRD, P.O. 

Box 7611, Washington, DC 

20044–7611. 

During the public comment period, 

the proposed Consent Decree may be 

examined and downloaded at this 

Justice Department website: https://

www.justice.gov/enrd/consent-decrees. 

If you require assistance accessing the 

proposed Consent Decree, you may 

request assistance by email or by mail 

to the addresses provided above for 

submitting comments. 

Kathryn C. Macdonald, 

Assistant Section Chief, Environmental 

Enforcement Section, Environment and 

Natural Resources Division. 

[FR Doc. 2024–28520 Filed 12–5–24; 8:45 am] 

BILLING CODE 4410–15–P 

DEPARTMENT OF JUSTICE 

Bureau of Prisons 

Annual Determination of Average Cost 

of Incarceration Fee (COIF) 

AGENCY: Bureau of Prisons, Justice. 

ACTION: Notice. 

SUMMARY: Pursuant to regulations, the 

Bureau of Prisons publishes the Fiscal 

Year (FY) 2023 Cost of Incarceration Fee 

(COIF) for Federal inmates. 

DATES: December 6, 2024. 

ADDRESSES: Office of General Counsel, 

Federal Bureau of Prisons, 320 First 

Street NW, Washington, DC 20534. 

FOR FURTHER INFORMATION CONTACT: 

Daniel J. Crooks III, Assistant General 

Counsel/Rules Administrator, Federal 

Bureau of Prisons, at the address above 

or at (202) 353–4885. 

SUPPLEMENTARY INFORMATION: Title 28 of 

the Code of Federal Regulations, part 

505, allows for assessment of a fee to 

cover the average cost of incarceration 

for Federal inmates. We calculate the 

cost of incarceration fee (COIF) by 

dividing the number representing the 

Bureau of Prisons (Bureau) facilities’ 

monetary obligation (excluding 

activation costs) by the number of 

inmate-days incurred for the fiscal year, 

and then by multiplying the quotient by 

the number of days in the fiscal year. 

Based on FY 2023 data, the average 

annual COIF for a Federal inmate 

housed in a Bureau or non-Bureau 

facility in FY 2023 was $44,090 

($120.80 per day). The average annual 

COIF for a Federal inmate housed in a 

Residential Reentry Center for FY 2023 

was $41,437 ($113.53 per day). (Please 

note: There were 365 days in FY 2023.) 

James Wills, 

Assistant Director/General Counsel, Federal 

Bureau of Prisons. 

[FR Doc. 2024–28743 Filed 12–5–24; 8:45 am] 

BILLING CODE 4410–05–P 

DEPARTMENT OF LABOR 

Mine Safety and Health Administration 

Petition for Modification of Application 

of Existing Mandatory Safety 

Standards 

AGENCY: Mine Safety and Health 

Administration, Labor. 

ACTION: Notice. 

SUMMARY: This notice is a summary of 

a petition for modification submitted to 

the Mine Safety and Health 

Administration (MSHA) by Peabody 

Midwest Mining, LLC. 

DATES: All comments on the petition 

must be received by MSHA’s Office of 

Standards, Regulations, and Variances 

on or before January 6, 2025. 

ADDRESSES: You may submit comments 

identified by Docket No. MSHA–2024– 

0089 by any of the following methods: 

1. Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 


lotter on DSK11XQN23PROD with NOTICES1